YI

YI

111 Inc

111, Inc. operates an integrated online and offline healthcare platform in China, offering B2C and B2B services. It provides pharmacy products, supply chain integration, online consultation, inventory management, and data services to pharmacies and medical professionals.

⚕️ Healthcare NASDAQ Listed 2018 ¥ CNY
$1,000 invested 5 years ago $64today

Score Overview

1 Year
Score
Net Growth73.98%
Net TrendGrew
Net Income Consistency
Rev Growth-15.19%
Rev TrendShrank
Revenue Consistency
5 Years
Score6.7
Net Growth96.31%
Net Trend80%
Net Income Consistency
Rev Growth48.89%
Rev Trend60%
Revenue Consistency
All Time
Score
Net Growth95.57%
Net Trend71%
Net Income Consistency
Rev Growth6x
Rev Trend71%
Revenue Consistency

See the full market ranking →

111 Inc fundamental performance

Between 2020 and 2025, revenue grew from ¥ 8.20B to ¥ 12.21B and net income went from -¥ 456M to -¥ 16M. Revenue increased in 3 of those 5 years; net income in 4.

111 Inc currently holds a 5-year HDB Score of 6.7 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 3.78
1 Year2025-08-12
$ 6.67-43.33%
5 Years2021-08-12
$ 59.30-93.63%
All Time2018-09-12
$ 138.00-97.26%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2025¥ 12.21B-¥ 16M¥ 611M
2024¥ 14.40B-¥ 64M¥ 462M
2023¥ 14.94B-¥ 392M¥ 653M
2022¥ 13.51B-¥ 416M¥ 879M
2021¥ 12.42B-¥ 669M¥ 843M
2020¥ 8.20B-¥ 456M¥ 1.48B
2019¥ 3.95B-¥ 499M¥ 613M
IPO2018¥ 1.78B-¥ 380M¥ 1.10B

Explore beyond YI

You're looking at 111 Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies